KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Net Cash Flow: 2019-2024

Historic Net Cash Flow for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $25.6 million.

  • AbCellera Biologics' Net Cash Flow rose 60.37% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 9.19%. This contributed to the annual value of $25.6 million for FY2024, which is 110.06% up from last year.
  • AbCellera Biologics' Net Cash Flow amounted to $25.6 million in FY2024, which was up 110.06% from -$254.6 million recorded in FY2023.
  • AbCellera Biologics' 5-year Net Cash Flow high stood at $586.6 million for FY2020, and its period low was -$254.6 million during FY2023.
  • For the 3-year period, AbCellera Biologics' Net Cash Flow averaged around -$102.0 million, with its median value being -$76.9 million (2022).
  • Per our database at Business Quant, AbCellera Biologics' Net Cash Flow soared by 20,389.28% in 2020 and then slumped by 231.15% in 2023.
  • AbCellera Biologics' Net Cash Flow (Yearly) stood at $586.6 million in 2020, then crashed by 115.61% to -$91.5 million in 2021, then grew by 16.01% to -$76.9 million in 2022, then plummeted by 231.15% to -$254.6 million in 2023, then spiked by 110.06% to $25.6 million in 2024.